Revenue (Tables)

6 Months Ended

Jun. 30, 2024

Disaggregation of Revenue [Line Items]

Disaggregation of Revenue [Table Text Block]

In the following tables, revenue is disaggregated by primary geographical markets and major goods and service lines.

	Reportable Segments
	Three Months Ended
	June 30, 2024						July 2, 2023
	Life Sciences		Diagnostics		Total		Life Sciences		Diagnostics		Total
	(In thousands)
Primary geographical markets
Americas	$	168,413	$	139,370	$	307,783	$	184,795	$	134,032	$	318,827
Europe	67,358		117,230		184,588		74,707		116,910		191,617
Asia	78,076		121,238		199,314		76,851		121,771		198,622
	$	313,847	$	377,838	$	691,685	$	336,353	$	372,713	$	709,066
Major goods/service lines
Life Sciences reagents	$	176,852	$	—	$	176,852	$	192,208	$	—	$	192,208
Life Sciences instruments	86,252		—		86,252		100,101		—		100,101
Life Sciences software	50,743		—		50,743		44,044		—		44,044
Reproductive health	—		129,175		129,175		—		128,621		128,621
Applied genomics	—		51,287		51,287		—		59,097		59,097
Immunodiagnostics	—		197,376		197,376		—		184,995		184,995
	$	313,847	$	377,838	$	691,685	$	336,353	$	372,713	$	709,066

	Reportable Segments
	Six Months Ended
	June 30, 2024						July 2, 2023
	Life Sciences		Diagnostics		Total		Life Sciences		Diagnostics		Total
	(In thousands)
Primary geographical markets
Americas	$	324,741	$	277,396	$	602,137	$	348,649	$	272,206	$	620,855
Europe	137,003		226,147		363,150		154,992		221,522		376,514
Asia	155,140		221,178		376,318		161,153		225,409		386,562
	$	616,884	$	724,721	$	1,341,605	$	664,794	$	719,137	$	1,383,931
Major goods/service lines
Life Sciences reagents	$	354,077	$	—	$	354,077	$	382,086	$	—	$	382,086
Life Sciences instruments	167,162		—		167,162		196,275		—		196,275
Life Sciences software	95,645		—		95,645		86,433		—		86,433
Reproductive health	—		253,050		253,050		—		250,742		250,742
Applied genomics	—		98,734		98,734		—		122,507		122,507
Immunodiagnostics	—		372,937		372,937		—		345,888		345,888
	$	616,884	$	724,721	$	1,341,605	$	664,794	$	719,137	$	1,383,931